Question 82

Dutasteride is indicated to treat symptoms associated with benign prostatic hyperplasia.

Dutasteride is specifically indicated for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate that can cause urinary difficulties.

A) generalized-onset seizures.

Generalized-onset seizures are a type of seizure that affects both sides of the brain and are not treated with dutasteride. This option is incorrect as dutasteride has no role in seizure management.

B) Parkinson's disease.

Parkinson's disease is a neurodegenerative disorder that affects movement and does not involve the use of dutasteride for treatment. This option is incorrect since dutasteride is not indicated for neurological conditions.

C) benign prostatic hyperplasia.

This option is correct as dutasteride is approved for the treatment of symptoms associated with benign prostatic hyperplasia. It works by inhibiting the conversion of testosterone to dihydrotestosterone, which is a contributing factor to prostate enlargement.

D) rheumatoid arthritis.

Rheumatoid arthritis is an inflammatory disorder that affects the joints and is not treated with dutasteride. This option is incorrect as dutasteride does not address autoimmune conditions.

Conclusion

Dutasteride's indication for the treatment of benign prostatic hyperplasia makes it the correct choice, as it specifically targets the symptoms related to this condition. The other options do not align with the pharmacological action of dutasteride, reinforcing that it is not an appropriate treatment for seizures, Parkinson's disease, or rheumatoid arthritis.